γ-Aminobutyric Acid and Derivatives Reduce the Incidence of Acute Pain after Herpes Zoster- A Systematic Review and Meta-analysis
Herpes zoster (HZ) causes considerable pain and distress, and γ-Aminobutyric acid (GABA) and its derivatives are assumed to control this, but the available data are inconsistent. This metaanalysis and systematic review aimed to assess the effectiveness of GABA derivatives in the prevention of acute...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2020
|
| Sorozat: | CURRENT PHARMACEUTICAL DESIGN
26 No. 25 |
| doi: | 10.2174/1381612826666200605120242 |
| mtmt: | 31336803 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/21194 |
| LEADER | 02900nab a2200361 i 4500 | ||
|---|---|---|---|
| 001 | publ21194 | ||
| 005 | 20210414091016.0 | ||
| 008 | 210414s2020 hu o 0|| zxx d | ||
| 022 | |a 1381-6128 | ||
| 024 | 7 | |a 10.2174/1381612826666200605120242 |2 doi | |
| 024 | 7 | |a 31336803 |2 mtmt | |
| 040 | |a SZTE Publicatio Repozitórium |b hun | ||
| 041 | |a zxx | ||
| 100 | 1 | |a Wuttapon Sadaeng | |
| 245 | 1 | 0 | |a γ-Aminobutyric Acid and Derivatives Reduce the Incidence of Acute Pain after Herpes Zoster- A Systematic Review and Meta-analysis |h [elektronikus dokumentum] / |c Wuttapon Sadaeng |
| 260 | |c 2020 | ||
| 300 | |a 3026-3038 | ||
| 490 | 0 | |a CURRENT PHARMACEUTICAL DESIGN |v 26 No. 25 | |
| 520 | 3 | |a Herpes zoster (HZ) causes considerable pain and distress, and γ-Aminobutyric acid (GABA) and its derivatives are assumed to control this, but the available data are inconsistent. This metaanalysis and systematic review aimed to assess the effectiveness of GABA derivatives in the prevention of acute herpetic pain. The meta-analysis was conducted following the PRISMA guidelines using PICO format, registered in PROSPERO number CRD42018095758. PubMed, Web of Science, Ovid, Scopus, and EMBASE databases were searched. Records were included if they were randomized controlled trials of patients undergoing HZ infection, investigating the effect of GABA derivatives versus placebo in the treatment of HZ pain. Eligible trials were evaluated for the risk of bias. Then data were extracted and analysed. The number of patients with observed presence of pain after treatment was used to calculate odds ratio in a random effect model with the DerSimonian-Laird estimator. The I 2 statistic was analysed for heterogeneity. The potential risk of bias was measured using Egger's regression test. The metaanalysis included three randomized controlled trials with a total of 297 patients. The incidence of acute HZ pain events for GABA group was significantly lower compared to placebo group,18/148 vs 44/159, respectively (OR = 0.36; 95% CI = 0.14 to 0.93; Z = 2.11; P = 0.035), Egger's test yielded P = 0.308. In conclusion, the present meta-analysis demonstrates that GABA derivatives reduce the incidence of acute herpetic pain. However, additional, well-designed randomized clinical trials are needed to determine their dose- and time-dependency regarding this symptom. | |
| 700 | 0 | 1 | |a Márta Katalin |e aut |
| 700 | 0 | 1 | |a Mátrai Péter |e aut |
| 700 | 0 | 1 | |a Hegyi Péter |e aut |
| 700 | 0 | 1 | |a Tóth Barbara |e aut |
| 700 | 0 | 1 | |a Németh Balázs |e aut |
| 700 | 0 | 1 | |a Czumbel László Márk |e aut |
| 700 | 0 | 2 | |a Sang-Ngoen Thanyaporn |e aut |
| 700 | 0 | 2 | |a Gyöngyi Zoltán |e aut |
| 700 | 0 | 2 | |a Varga Gábor |e aut |
| 700 | 0 | 2 | |a Révész Péter |e aut |
| 700 | 0 | 2 | |a Szanyi István |e aut |
| 700 | 0 | 2 | |a Karádi Kázmér |e aut |
| 700 | 0 | 2 | |a Gerber Gábor |e aut |
| 856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/21194/1/0011B.pdf |z Dokumentum-elérés |